• P-ISSN 0974-6846 E-ISSN 0974-5645

Indian Journal of Science and Technology


Indian Journal of Science and Technology

Year: 2023, Volume: 16, Issue: 2, Pages: 77-81

Original Article

Prescribing Pattern of Levetiracetam in Epilepsy Patients: A Cross-Sectional Study in a Tertiary Care Centre in Manipur

Received Date:16 November 2022, Accepted Date:02 December 2022, Published Date:06 January 2023


Objective: The objective is to shed light on the prescribing pattern of levetiracetam, a newer antiepileptic drug, in the treatment of different types of epilepsy. Methods: A record-based cross-sectional study of epilepsy patients who reported to the Therapeutic Drug Monitoring Unit in the Department of Pharmacology, Regional Institute of Medical Sciences, Manipur, was conducted. Case records of patients receiving levetiracetam and reporting from January 2017 to December 2020 were included. The patient’s age, gender, and weight; clinical diagnosis; levetiracetam dose; and other co-administered AEDs were all examined. Findings: Of the 17 cases, the majority of the patients were adults, and 52.9% were males. The patients’ average body weight (kg) was 49.8  9.4. Generalised tonic-clonic seizures (GTCS) constituted the majority of the cases (47.1%), followed by simple partial seizures, complex partial seizures (23.5% of each), and absence seizures (5.9%). 70.11% of the cases received LEV monotherapy, while the remaining cases were prescribed combination therapy. LEV alone was prescribed in 87.5% of GTCS cases. The median daily dose of LEV was 1000 mg (IQR-625). Novelty : The observation that levetiracetam alone is prescribed in the majority of GTCS cases, the commonest type of epilepsy, is an eye-opener for another new monotherapy option for GTCS. Keywords: Prescribing pattern; Levetiracetam; Antiepileptic; Epilepsy; Monotherapy


  1. Nakken KO, Brodtkorb E. Are the new anti-epileptic drugs any better than their predecessors? . Tidsskr Nor Laegeforen. 2020;140. Available from: https://doi.org/10.4045/tidsskr.20.0657
  2. Smith MD, Metcalf CS, Wilcox KS. Pharmacotherapy of the Epilepsies. In: BL, HDR, KB., eds. Goodman & Gillman’s The Pharmacological Basis of Therapeutics. (pp. 302-326) McGraw-Hill Education. 2017.
  3. Bilbao-Meseguer I, Barrasa H, Asín-Prieto E, Alarcia-Lacalle A, Rodríguez-Gascón A, Maynar J, et al. Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function. Pharmaceutics. 2021;13(10):1690. Available from: https://doi.org/10.3390/pharmaceutics13101690
  4. Sori RK, Gandigawad P. Drug utilization pattern of anti-epileptic drugs in tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology. 2020;11(0):1. Available from: https://doi.org/10.5455/njppp.2021.11.11323202007122020
  5. Mehndiratta MM, Sarma GK, Tripathi MR, Ravat S, Gopinath S, Babu S, et al. A Multicenter, Cross-Sectional, Observational Study on Epilepsy and its Management Practices in India. Neurology India. 2022;70(5):2031. Available from: https://doi.org/10.4103/0028-3886.359162
  6. Joshi R, Tripathi M, Gupta P, Gulati S, Gupta YK. Prescription pattern of antiepileptic drugs in a tertiary care center of India. Indian Journal of Pharmacology. 2020;52:283–292. Available from: https://doi.org/10.4103/ijp.IJP_507_17
  7. Rai J, Kaushik S, Agrawal H, Mahajan A, Yadav P. Pattern of antiepileptic drug utilization in epilepsy patients in outpatient departments of a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology. 2022;13(0):1. Available from: https://doi.org/10.1111/j.1365-2141.1975.tb01817.x
  8. Kacha M, Jain AB, Dave N, Chaturvedi AN, Shah A. Evaluating the prescription pattern of newly diagnosed epilepsy patients in India - a real-world observational study. International Journal Of Community Medicine And Public Health. 2022;9(10):3673. Available from: https://doi.org/10.18203/2394-6040.ijcmph20222554
  9. Uppal S, Uppal S, Panchal G. Recent updates on Levetiracetam. IP Indian Journal of Neurosciences. 2022;8(1):21–30. Available from: https://doi.org/10.18231/j.ijn.2022.005
  10. Fallah R, Shafiei A, Firouzabadi D, Fathi F, A. Evaluation of the efficacy and tolerability of levetiracetam as add-on therapy in intractable epilepsy of children. Iranian Journal of Child Neurology. 2022;16(2):77–84. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047840/pdf/ijcn-16-77.pdf


© 2023 Devi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Published By Indian Society for Education and Environment (iSee)


Subscribe now for latest articles and news.